{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:24:57Z","timestamp":1772511897420,"version":"3.50.1"},"reference-count":51,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SPI"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>The objectives of this study were to examine whether the systemic administration of recombinant human erythropoietin (rHuEPO) and its long-lasting derivative darbepoetin alfa expedited functional recovery in a rat model of sciatic nerve injury, and to compare the effects of these agents in the model.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Thirty male Sprague\u2013Dawley rats received a crush injury to the left sciatic nerve and subsequently underwent either placebo treatment, daily injections of rHuEPO, or weekly injections of darbepoetin alfa.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Both rHuEPO and darbepoetin alfa were effective in reducing neurological impairment and improving compound muscle action potentials following nerve injury. Darbepoetin alfa, however, shortened the duration of peripheral nerve recovery and facilitated recovery from the neurological and electrophysiological impairment following crush injury significantly better than rHuEPO. Examination of the footprint length factor data revealed that darbepoetin alfa\u2013treated animals recovered preinjury function by postoperative Day 10, 4 days earlier than animals treated with rHuEPO and 11 days earlier than animals treated with placebo.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>These results suggest that recovery of neurological function in a model of peripheral nerve injury is more rapid with weekly administration of darbepoetin alfa than with daily rHuEPO treatment. Agents that facilitate nerve regeneration have the potential to limit the extent of motor endplate loss and muscle atrophy. The administration of EPO in its long-lasting recombinant forms affords significant neuroprotection in peripheral nerve injury models and may hold promise for future clinical applications.<\/jats:p><\/jats:sec>","DOI":"10.3171\/spi-07\/12\/645","type":"journal-article","created":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T21:37:59Z","timestamp":1197581879000},"page":"645-651","source":"Crossref","is-referenced-by-count":28,"title":["Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury"],"prefix":"10.3171","volume":"7","author":[{"given":"Giovanni","family":"Grasso","sequence":"first","affiliation":[{"name":"Neurosurgical Clinic, Department of Clinical Neurosciences, University of Palermo; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Meli","sequence":"additional","affiliation":[{"name":"Neurosurgical Clinic, Department of Clinical Neurosciences, University of Palermo; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Fodale","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Calapai","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine and Pharmacology (Section of Pharmacology), and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Buemi","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico G.","family":"Iacopino","sequence":"additional","affiliation":[{"name":"Neurosurgical Clinic, Department of Clinical Neurosciences, University of Palermo; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-0070645","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0006-8993(02)03239-0","article-title":"Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis","volume":"952","author":"Agnello","year":"2002"},{"key":"b2-0070645","series-title":"J Urol","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1097\/01.ju.0000176808.94610.dd","article-title":"Erythropoietin promotes the recovery of erectile function following cavernous nerve injury","volume":"174","author":"Allaf","year":"2005"},{"key":"b3-0070645","series-title":"Mol Neurobiol","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF02740752","article-title":"Priming events and retrograde injury signals. A new perspective on the cellular and molecular biology of nerve regeneration","volume":"13","author":"Ambron","year":"1996"},{"key":"b4-0070645","series-title":"Stroke","first-page":"1071","article-title":"Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats","volume":"36","author":"Belayev","year":"2005"},{"key":"b5-0070645","series-title":"J Neurosci Methods","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-0270(00)00281-8","article-title":"Video analysis of standing\u2014-an alternative footprint analysis to assess functional loss following injury to the rat sciatic nerve","volume":"102","author":"Bervar","year":"2000"},{"key":"b6-0070645","series-title":"Restor Neurol Neurosci","first-page":"341","article-title":"Erythropoietin enhances neurological recovery after experimental spinal cord injury","volume":"23","author":"Boran","year":"2005"},{"key":"b7-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000"},{"key":"b8-0070645","series-title":"J Nephrol","first-page":"97","article-title":"Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia","volume":"15","author":"Buemi","year":"2002"},{"key":"b9-0070645","series-title":"Clin Sci (Lond)","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/cs1030275","article-title":"Erythropoietin and the brain: from neurodevelopment to neuroprotection","volume":"103","author":"Buemi","year":"2002"},{"key":"b10-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium from ischemiareperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvillo","year":"2003"},{"key":"b11-0070645","series-title":"Eur J Neurosci","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1460-9568.2006.04606.x","article-title":"Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury","volume":"23","author":"Campana","year":"2006"},{"key":"b12-0070645","series-title":"Eur J Neurosci","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1046\/j.1460-9568.2003.02875.x","article-title":"Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury","volume":"18","author":"Campana","year":"2003"},{"key":"b13-0070645","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-2999(02)01292-X","article-title":"Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils","volume":"437","author":"Catania","year":"2002"},{"key":"b14-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1073\/pnas.042693799","article-title":"Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury","volume":"99","author":"Celik","year":"2002"},{"key":"b15-0070645","series-title":"Exp Hematol","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0301-472X(99)00159-9","article-title":"A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit","volume":"28","author":"D'Andrea","year":"2000"},{"key":"b16-0070645","series-title":"Nature","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/35088074","article-title":"Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades","volume":"412","author":"Digicaylioglu","year":"2001"},{"issue":"Suppl 3","key":"b17-0070645","series-title":"Nephrol Dial Transplant","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ndt\/16.suppl_3.3","article-title":"Development and characterization of novel erythropoiesis stimulating protein (NESP)","volume":"16","author":"Egrie","year":"2001"},{"key":"b18-0070645","series-title":"Exp Hematol","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0301-472X(03)00006-7","article-title":"Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin","volume":"31","author":"Egrie","year":"2003"},{"key":"b19-0070645","series-title":"Mol Med","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002"},{"key":"b20-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1031753100","article-title":"Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo","volume":"100","author":"Erbayraktar","year":"2003"},{"key":"b21-0070645","series-title":"Mol Neurobiol","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF02740621","article-title":"The cellular and molecular basis of peripheral nerve regeneration","volume":"14","author":"Fu","year":"1997"},{"key":"b22-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9450","DOI":"10.1073\/pnas.142287899","article-title":"Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma","volume":"99","author":"Gorio","year":"2002"},{"key":"b23-0070645","series-title":"J Neurosurg Sci","first-page":"7","article-title":"Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage","volume":"45","author":"Grasso","year":"2001"},{"key":"b24-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1073\/pnas.082097299","article-title":"Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage","volume":"99","author":"Grasso","year":"2002"},{"key":"b25-0070645","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3171\/jns.2002.96.3.0565","article-title":"Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage?","volume":"96","author":"Grasso","year":"2002"},{"key":"b26-0070645","series-title":"Med Sci Monit","first-page":"BR1","article-title":"A new computed-assisted technique for experimental sciatic nerve function analysis","volume":"10","author":"Grasso","year":"2004"},{"key":"b27-0070645","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3171\/spi.2006.4.4.310","article-title":"Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative","volume":"4","author":"Grasso","year":"2006"},{"key":"b28-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"10659","DOI":"10.1073\/pnas.152321399","article-title":"Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury","volume":"99","author":"Junk","year":"2002"},{"key":"b29-0070645","series-title":"Pediatr Res","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1203\/00006450-199801000-00007","article-title":"Erythropoietin and erythropoietin receptor in the developing human central nervous system","volume":"43","author":"Juul","year":"1998"},{"key":"b30-0070645","series-title":"Early Hum Dev","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0378-3782(98)00030-9","article-title":"Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus","volume":"52","author":"Juul","year":"1998"},{"key":"b31-0070645","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.brainres.2005.10.078","article-title":"Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease","volume":"1068","author":"Kanaan","year":"2006"},{"key":"b32-0070645","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"39469","DOI":"10.1074\/jbc.M105832200","article-title":"Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia","volume":"276","author":"Kawakami","year":"2001"},{"key":"b33-0070645","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.20285","article-title":"A novel endogenous erythropoietin mediated pathway prevents axonal degeneration","volume":"56","author":"Keswani","year":"2004"},{"key":"b34-0070645","series-title":"Biol Neonate","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000068926","article-title":"Neuroprotective effect of erythropoietin on hypoxicischemic brain injury in neonatal rats","volume":"83","author":"Kumral","year":"2003"},{"key":"b35-0070645","series-title":"J Pediatr Surg","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0022-3468(00)90006-X","article-title":"Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight","volume":"35","author":"Ledbetter","year":"2000"},{"key":"b36-0070645","series-title":"Science","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004"},{"key":"b37-0070645","series-title":"Pediatr Res","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1203\/00006450-199609000-00002","article-title":"Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses","volume":"40","author":"Li","year":"1996"},{"key":"b38-0070645","series-title":"J Exp Biol","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1242\/jeb.01049","article-title":"Erythropoietin and the hypoxic brain","volume":"207","author":"Marti","year":"2004"},{"key":"b39-0070645","series-title":"Epilepsia","first-page":"175","article-title":"Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10","volume":"48","author":"Mikati","year":"2007"},{"key":"b40-0070645","series-title":"Oncologist","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1634\/theoncologist.9-4-451","article-title":"Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice","volume":"9","author":"Patton","year":"2004"},{"key":"b41-0070645","series-title":"Clin Ther","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/S0149-2918(03)80333-8","article-title":"A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia","volume":"25","author":"Schwartzberg","year":"2003"},{"key":"b42-0070645","series-title":"Spine","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1097\/01.BRS.0000096674.12519.12","article-title":"ISSLS prize winner: Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush","volume":"28","author":"Sekiguchi","year":"2003"},{"key":"b43-0070645","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1523\/JNEUROSCI.22-08-03052.2002","article-title":"The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, inter-leukin-1alpha, and interleukin-1beta","volume":"22","author":"Shamash","year":"2002"},{"key":"b44-0070645","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1523\/JNEUROSCI.21-24-09733.2001","article-title":"Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells","volume":"21","author":"Shingo","year":"2001"},{"key":"b45-0070645","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress","volume":"98","author":"Sir\u00e9n","year":"2001"},{"key":"b46-0070645","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.bjp.0704521","article-title":"A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats","volume":"135","author":"Springborg","year":"2002"},{"key":"b47-0070645","series-title":"Am J Nephrol","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000080452","article-title":"Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration","volume":"24","author":"Toto","year":"2004"},{"key":"b48-0070645","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20021067","article-title":"Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis","volume":"198","author":"Villa","year":"2003"},{"key":"b49-0070645","series-title":"Neuroreport","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1097\/00001756-199611250-00018","article-title":"Endoneurial injection of TNF-alpha produces neuropathic pain behaviors","volume":"7","author":"Wagner","year":"1996"},{"key":"b50-0070645","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/0306-4522(96)00127-3","article-title":"Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves","volume":"73","author":"Wagner","year":"1996"},{"key":"b51-0070645","series-title":"Trends Neurosci","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","article-title":"Glial activation: a driving force for pathological pain","volume":"24","author":"Watkins","year":"2001"}],"container-title":["Journal of Neurosurgery: Spine"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/7\/6\/article-p645.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/7\/6\/article-p645.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/7\/6\/article-p645.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T23:30:25Z","timestamp":1681601425000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/7\/6\/article-p645.xml"}},"subtitle":["Laboratory investigation"],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":51,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/spi-07\/12\/645","relation":{},"ISSN":["1547-5654"],"issn-type":[{"value":"1547-5654","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}